¿Existen las mismas resistencias de uropatógenos a antibióticos en los ámbitos de la atención primaria y hospitalario?

Rise in ciprofloxacin resistance in Escherichia coli from urinary tract infections from 1999–2004

“…This trend is present throughout the world and is related to increased use of quinolones as therapy for humans as well as in veterinary medicine [6]. Quinolone resistance rates of E. coli in our study were not as high as in Portugal and Spain [1,5], although the trend of rising resistance should be stopped by certain restrictions on their use.…”

“…It is usual to treat patients with uncomplicated bacterial cystitis using empirical antimicrobial therapy, according to known local resistance rates. Recent studies have demonstrated an increase in resistance to ␤-lactams, trimethoprim/sulphamethoxazole and quinolones among E. coli causing community-acquired UTIs [1][2][3][4][5][6]. Resistance occurs because of the increased use of these antimicrobials in a variety of human indications, as well as their use in veterinary medicine [6,7].…”